DetailsChartProfilRisikomatrixNachrichtenDokumente

Candriam Equities L Oncology Impact I/  LU1864482515  /

Fonds
NAV29.08.2024 Diff.+10,0999 Ertragstyp Ausrichtung Fondsgesellschaft
2.348,9700GBP +0,43% thesaurierend Aktien weltweit Candriam ▶
 

Monatliche Performance

  Jan Feb Mrz Apr Mai Jun Jul Aug Sep Okt Nov Dez Gesamt
2020 - - - 10,22 10,74 1,48 -1,69 0,14 7,21 -2,22 2,49 1,44 -
2021 0,09 -5,90 1,24 1,97 -2,18 6,26 -1,59 6,66 -1,78 1,68 -2,99 1,57 +4,39%
2022 -9,64 -1,76 6,66 -1,27 -1,71 3,82 4,16 1,30 -0,67 3,78 2,55 -4,40 +1,72%
2023 -0,19 -2,26 -0,73 1,15 -1,18 -2,43 -0,31 -0,51 -1,63 -5,81 4,68 5,01 -4,59%
2024 1,47 4,84 1,63 -2,53 0,79 1,91 4,08 1,25 - - - - -

Kennzahlen

  lfd. Jahr 6 Monate 1 Jahr 3 Jahre 5 Jahre
Volatilität 11,04% 10,59% 11,23% 14,38% -%
Sharpe Ratio 1,69 1,09 1,05 -0,04 -
Bester Monat +5,01% +4,84% +5,01% +6,66% +10,74%
Schlechtester Monat -2,53% -2,53% -5,81% -9,64% -9,64%
Maximaler Verlust -4,95% -4,95% -8,80% -18,83% -
Outperformance - - - - -
 
Alle Kurse in GBP

Tranchen

Titel   Ertragstyp Rückn. Preis 1 Jahr 3 Jahre
Candriam Equities L Oncology Imp... thesaurierend 2.602,5200 +20,84% +5,21%
Candriam Equities L Oncology Imp... thesaurierend 2.781,9299 +20,99% +5,60%
Candriam Equities L Oncology Imp... thesaurierend 2.348,9700 +15,26% +8,98%
Candriam Equities L Oncology Imp... ausschüttend 1.745,0000 +20,45% +4,20%
Candriam Equities L Oncology Imp... ausschüttend 21.888,0000 +13,64% -2,28%
Candriam Equities L Oncology Imp... thesaurierend 2.277,5801 +18,04% -3,19%
Candriam Equities L Oncology Imp... thesaurierend 1.939,1700 +15,63% -
Candriam Equities L Oncology Imp... thesaurierend 223,4200 +16,93% -5,89%
Candriam Equities L Oncology Imp... thesaurierend 260,3000 +16,72% +7,96%
Candriam Equities L Oncology Imp... ausschüttend 255,2100 +19,32% +1,32%
Candriam Equities L Oncology Imp... ausschüttend 207,1400 +20,33% +3,89%
Candriam Equities L Oncology Imp... thesaurierend 166,1300 +15,13% +8,61%
Candriam Equities L Oncology Imp... thesaurierend 276,4600 +17,71% +10,73%
Candriam Equities L Oncology Imp... thesaurierend 222,6200 +16,46% -7,00%
Candriam Equities L Oncology Imp... thesaurierend 310,6000 +20,33% +3,88%
Candriam Equities L Oncology Imp... thesaurierend 209,2600 +17,99% -
Candriam Equities L Oncology Imp... thesaurierend 3.123,4500 +20,45% +4,20%
Candriam Equities L Oncology Imp... thesaurierend 167,1400 - -
Candriam Equities L Oncology Imp... thesaurierend 296,5000 +19,32% +1,30%

Performance

lfd. Jahr  
+14,06%
6 Monate  
+7,22%
1 Jahr  
+15,26%
3 Jahre  
+8,98%
5 Jahre     -
10 Jahre     -
seit Beginn  
+56,60%
Jahr
2023
  -4,59%
2022  
+1,72%
2021  
+4,39%